Treatment of Advanced Thyroid Cancer
暂无分享,去创建一个
[1] S. Larson,et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. , 2013, The New England journal of medicine.
[2] S. Larson,et al. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans. , 2012, Thyroid : official journal of the American Thyroid Association.
[3] S. Carty,et al. American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. , 2011, Thyroid : official journal of the American Thyroid Association.
[4] R. Kelley,et al. Evidence for drugs and biomarkers in oncology guidelines (GLs): A survey of the National Comprehensive Cancer Network (NCCN) colon cancer panel. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] N. Lee,et al. The role of external beam radiotherapy in the treatment of papillary thyroid cancer. , 2006, Endocrine-related cancer.
[6] E. Baudin,et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.
[7] S. Larson,et al. Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. , 2001, Thyroid : official journal of the American Thyroid Association.